- Home
- XLO vs USIO Comparison
XLO vs USIO Comparison
Compare XLO & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XLO | USIO |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 37.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XLO | USIO |
|---|---|---|
| Price | $0.65 | $1.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 527.5K | 74.8K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $31,804,000.00 | ★ $83,710,461.00 |
| Revenue This Year | $626.78 | $5.99 |
| Revenue Next Year | $79.08 | $11.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 588.40 | 1.46 |
| 52 Week Low | $0.62 | $1.24 |
| 52 Week High | $1.70 | $2.92 |
Technical Indicators
Market Signals| Indicator | XLO | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.65 | 42.81 |
| Support Level | $0.65 | $1.41 |
| Resistance Level | $0.68 | $1.37 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 17.98 | 16.67 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.